Answers are grounded in this paper and cite their sources.
Experimental study demonstrates that dexamethasone inhibits cavernous malformations in mice, highlighting dual PDCD10 roles across the gut-brain axis.
in the gut epithelium. Last, we show that treatment with dexamethasone potently inhibits CCM formation in mice because of the combined effect of action at both brain endothelial cells and gut epithelial cells. These studies define a gut-brain disease axis in an experimental model of CCM in which a single gene is required for two critical components: gut epithelial function and brain endothelial signaling.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: